The slide presentation of IQVIA Institute's webinar on The Global Use of Medicines 2024 report is now available. Download the content to learn what experts think about the report’s finding on the outlook of global medicine.Contact Us Investor Relations Customer Portal Careers Code of Conduct Even...
This annual trend report from the IQVIA Institute quantifies the impact of market dynamics and examines the spending and usage of medicines in 2023 and the outlook to 2028, globally and for specific therapy areas and countries. This report is intended to
Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, discusses key findings from their Global Use of Medicines 2024 report as well as the significant projected growth in spending and growth in diabetes and global obesity...
Published by , Nov 22, 2024 Global spending on medicine continues to grow. In 2022, approximately 1.48 trillion U.S. dollars had been spent on medicines, up from just 887 billion U.S. dollars in 2010. That number is expected to increase to over 1.9 trillion by the year 2027. Spending...
Launch of two first-in-class medicines in 2023 marks start of exciting phase… PRESS RELEASE 2024 Ferring announces full availability of ADSTILADRIN® (nadofaragene firadenovec-vncg) in the U.S. inPRESS RELEASE 2024on16 January 2024 ...
Health care organizations can help reduce emissions and cut down on waste across the value chain by supply chain optimization, clinical innovation, low-carbon medicines and transportation efficiency. Measuring sustainable outcomes.Measuring environmental impact and being able to compare and learn from peers...
Dupilumab is a prescription medication used, along with other medicines, to treat asthma. In clinical trials, dupilumab worked well in patients with moderate-to-severe asthma, reducing the number of asthma attacks and improving lung function, characterized by easier breathing. To determine how well ...
19 Nature has also been an important source of medicines, and thus reduced diversity also constrains the discovery of new medicines. Communities are healthier if they have access to high-quality green spaces that help filter air pollution, reduce air and ground temperatures, and provide ...
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.